This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Novo Nordisk A/S
Drug Names(s): long-acting rFVIII derivative, rFVIII glycopegylated, NN7088, NNC 0129-0000-1003
Description: NN7088 is a glyco-PEGylated derivative of recombinant factor VIII. In the coagulation cascade, factor VIII acts as a cofactor for factor IXa in the activation of factor X.
Pink Sheet FDA Performance Tracker: CBER Approvals
Pink Sheet FDA Performance Tracker: User Fee Goal Dates
Pink Sheet US FDA, Advisory Committees Rarely Disagree
Additional information available to subscribers only: